scout
|Videos|June 17, 2016

Fulvestrant Plus Palbociclib in Breast Cancer

Joanne Blum, MD, PhD, FACP, physician, Texas Oncology, discusses the combination of fulvestrant and palbociclib (Ibrance) in patients with breast cancer, as well as the synergy fulvestrant has with other CDK4/6 inhibitors.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME